Galectin Therapeutics (GALT) Receivables - Other (2010 - 2011)
Galectin Therapeutics (GALT) posted quarterly Receivables - Other of -$234000.0 for Q1 2011.
Analysis
Galectin Therapeutics (GALT) Receivables - Other (2010 - 2011) Analysis & Trends
Galectin Therapeutics' Receivables - Other history runs 1 years deep, the most recent figure standing at -$234000.0 for Q1 2011.
- In Q1 2011, Receivables - Other changed N/A year-over-year to -$234000.0; the TTM figure through Dec 2011 stood at -$234000.0 (changed N/A YoY), while the FY2011 annual figure was -$234000.0, down 200.0% from the prior year.
- Receivables - Other for Q1 2011 stood at -$234000.0.
- The five-year high for Receivables - Other was -$234000.0 in Q1 2011, with the low at -$234000.0 in Q1 2011.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Galectin Therapeutics | 304.34 Mn | 304.34 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2011 | -234,000.00 |
| Dec 31, 2010 | 234,000.00 |